Parag Mallick
CIK: 0001857948
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nautilus Biotechnology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 2, 2026NAUT
Nautilus Biotechnology, Inc.
Award(A)DirectStock Option (Right to Buy)
280K shares- - May 12, 2025NAUT
Nautilus Biotechnology, Inc.
Purchase(P)Direct1.5K shares at avg. $0.73$1K - May 8, 2025NAUT
Nautilus Biotechnology, Inc.
Purchase(P)Direct12K shares at avg. $0.73$9K - Mar 3, 2025NAUT
Nautilus Biotechnology, Inc.
Award(A)DirectStock Option (Right to Buy)
280K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | NAUT Nautilus Biotechnology, Inc. | Award(A) Stock Option (Right to Buy) | 280,000 | - | - | Direct |
| May 12, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase(P) | 1,500 | $0.73 | $1,098 | Direct |
| May 8, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase(P) | 12,000 | $0.73 | $8,788 | Direct |
| Mar 3, 2025 | NAUT Nautilus Biotechnology, Inc. | Award(A) Stock Option (Right to Buy) | 280,000 | - | - | Direct |
1-4 of 4 transactions
About Mallick Parag
Mallick Parag (SEC CIK 0001857948) files insider reports with the SEC as Chief Scientist of Nautilus Biotechnology, Inc. (NAUT).
Signal8 holds 3 ownership filings by Mallick Parag, all Form 4s, filed between Mar 4, 2025 and Mar 4, 2026. Those filings report 4 transactions, from Mar 3, 2025 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mallick Parag's filings is in SEATTLE, WA.
Recent filings by Mallick Parag
Other insiders filing for Nautilus Biotechnology, Inc. (NAUT)
- Posard Matthew L., Director
- NAZEM FARZAD, Director
- Akinsanya Karen, Director
- McIlwain Matthew S, Director
- Epperly Melissa B,, Director
- AH Equity Partners Bio II, L.L.C., 10% Owner